Management of superficial and deep-seated Staphylococcus aureus skin and soft tissue infections in sub-Saharan Africa: a post hoc analysis of the StaphNet cohort
The incidence of Staphylococcus aureus skin and soft tissue infection (SSTI) is high in sub-Saharan Africa. This is fueled by a high prevalence of Panton-Valentine leukocidin (PVL), which can be associated with necrotizing disease. The aim was to describe the clinical presentation and the treatment of SSTI in the African setting and to identify challenges in the management.
Patients (n = 319) were recruited in DR Congo (n = 56, 17.6%), Gabon (n = 89, 27.9%), Mozambique (n = 79, 24.8%) and Tanzania (n = 95, 29.8%) during the prospective observational StaphNet cohort study (2010–2015). A physician recorded the clinical management in standardized questionnaires and stratified the entity of SSTI into superficial (sSSTI) or deep-seated (dSSTI). Selected virulence factors (PVL, β hemolysin) and multilocus sequence types (MLST) were extracted from whole genome sequencing data.
There were 220/319 (69%) sSSTI and 99/319 (31%) dSSTI. Compared to sSSTI, patients with dSSTI were more often hospitalized (13.2 vs. 23.5%, p = 0.03), HIV-positive (7.6 vs. 15.9%, p = 0.11), and required more often incision and drainage (I&D, 45.5 vs. 76.5%, p = 0.04). The proportion of an adequate antimicrobial therapy increased marginally from day 1 (empirical therapy) to day 3 (definite therapy), for sSSTI (70.7 to 72.4%) and dSSTI (55.4 to 58.9%). PVL was a risk factor for I&D (OR = 1.7, p = 0.02) and associated with MLST clonal complex CC121 (OR = 2.7, p < 0.001).
Appropriate antimicrobial agents and surgical services to perform I&D were available for the majority of patients. Results from susceptibility testing should be considered more efficiently in the selection of antimicrobial therapy.
KeywordsStaphylococcus aureus Skin and soft tissue infection Sub-Saharan Africa Management Microbiology
This study received grants from the Deutsche Forschungsgemeinschaft (HE 1850/11-1 to M.H., KE 700/3-1 to W.V.K., ME 3205/4-1 to A.M., and PE 296/6-1 to G.P.).
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 3.Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52. https://doi.org/10.1093/cid/ciu444.CrossRefPubMedGoogle Scholar
- 6.Ruffing U, Alabi A, Kazimoto T, Vubil DC, Akulenko R, Abdulla S, et al. Community-associated Staphylococcus aureus from Sub-Saharan Africa and Germany: a cross-sectional geographic correlation study. Sci Rep. 2017;7:154. https://doi.org/10.1038/s41598-017-00214-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Gutierrez K, Halpern MS, Sarnquist C, Soni S, Arroyo AC, Maldonado Y. Staphylococcal infections in children, California, USA, 1985–2009. Emerg Infect Dis. 2013;19:10–20. https://doi.org/10.3201/eid1901.111740 (quiz 185).
- 11.Nurjadi D, Friedrich-Jänicke B, Schäfer J, Van Genderen PJJ, Goorhuis A, Perignon A, et al. Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe. Clin Microbiol Infect. 2015;21:e1–10. https://doi.org/10.1016/j.cmi.2015.01.016.CrossRefGoogle Scholar
- 12.Lebughe M, Phaku P, Niemann S, Mumba D, Peters G, Muyembe-Tamfum J-J et al. The impact of the Staphylococcus aureus virulome on infection in a developing country: a cohort study. Front Microbiol. 2017;8. https://doi.org/10.3389/fmicb.2017.01662.
- 13.Li T, Yu X, Xie J, Xu Y, Shang Y, Liu Y, et al. Carriage of virulence factors and molecular characteristics of Staphylococcus aureus isolates associated with bloodstream, and skin and soft tissue infections in children. Epidemiol Infect. 2013;141:2158–62. https://doi.org/10.1017/s0950268812002919.CrossRefPubMedGoogle Scholar
- 15.Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250–6. https://doi.org/10.1097/01.ccm.0000050454.01978.3b.CrossRefPubMedGoogle Scholar
- 16.Institute Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 27th ed. Wayne: CLSI; 2017.Google Scholar
- 17.Strauss L, Ruffing U, Abdulla S, Alabi A, Akulenko R, Garrine M, et al. Detecting Staphylococcus aureus virulence and resistance genes: a comparison of whole-genome sequencing and DNA microarray technology. J Clin Microbiol. 2016;54:1008–16. https://doi.org/10.1128/JCM.03022-15.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Egyir B, Guardabassi L, Sorum M, Nielsen SS, Kolekang A, Frimpong E, et al. Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in Ghana. PLOS One. 2014;9:e89716. https://doi.org/10.1371/journal.pone.0089716.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Nurjadi D, Olalekan AO, Layer F, Shittu AO, Alabi A, Ghebremedhin B, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69:2361–8. https://doi.org/10.1093/jac/dku174.CrossRefPubMedGoogle Scholar
- 21.Watanabe S, Ohnishi T, Yuasa A, Kiyota H, Iwata S, Kaku M, et al. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2017;23:503–11. https://doi.org/10.1016/j.jiac.2017.05.006.CrossRefPubMedGoogle Scholar
- 27.Nelson CE, Chen A, McAndrew L, Tay KY, Balamuth F. Management of skin and soft-tissue infections before and after clinical pathway implementation. Clin Pediatr (Phila). 2017:9922817738329. https://doi.org/10.1177/0009922817738329.